IPF Summit

The inaugural Idiopathic Pulmonary Fibrosis (IPF) Summit is the only event to focus solely on IPF.

This unique meeting is your opportunity to join the leading minds across biopharma and academia to reduce the expansive translational gap that exists in current IPF drug development.

Across 3 jam-packed days the brightest minds from the likes of Boehringer Ingelheim, Promedior, Fibrogen and many more will be sharing their insight and lessons learned to collectively enable the community to:

- Effectively translate into the clinic by better recapitulating IPF through robust in vitro and vivo models
- Define more meaningful preclinical endpoints to aid identification of novel targets and development of more effective IPF therapeutics
- Validate non-invasive biomarker and diagnostic techniques for back translation and ultimately achieve greater clinical benefit